Effects of WB-EMS and Protein Supplementation on LBM Maintenance During Intended Weight Loss
NCT ID: NCT03746977
Last Updated: 2019-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2018-01-25
2018-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A energy deficit of 500 kcal/d was intended however while group (1) focus consistently on energy restriction (500 kcal/d), in group (2) and (3) a combined physical activity (i.e. walking with a volume representing 250 kcal/d) and energy restriction (250 kcal/d) protocol was applied. Total protein uptake including protein supplementation was calculated to average around 1.2 g/kg body mass per day in groups (1) and 1.5 g/kg body mass/d in group (2) and (3). WB-EMS was applied 1.5x 20 min/week (i.e. each Tuesday and every second Thursday).
Primary study endpoint was LBM as determined by Dual Energy x-Ray Absorptiometry.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Whole Body Electromyostimulation and/or Protein Supplementation on Sarcopenic Obesity in 70+
NCT02857660
Utilizing Protein During Weight Loss to Impact Physical Function
NCT03074643
Protein Supplementation and Resistance Training to Prevent Fat-Free Mass Loss Following Metabolic-Bariatric Surgery
NCT07156552
Whey Protein Supplementation Associated With Resistance Training on Health Indicators in Trained Older Women
NCT03247192
Whey Protein Supplementation and Resistance Training in Older Women With Sarcopenic Obesity.
NCT03752359
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
energy restriction and protein supplementation
Energy restriction of 500 kcal/d and total Protein Uptake (including Supplementation) of 1.2 g/kg body mass/d
Protein
Protein supplementation 1.2 or 1.5 g/kg body mass/d
Energy restriction, walking and protein
Energy restriction of 250 kcal/d, increased energy consumption by walking (250 kcal/d) and total protein uptake (including supplementation) of 1.5 g/kg body mass/d
Protein
Protein supplementation 1.2 or 1.5 g/kg body mass/d
Walking
Walking with a volume corresponding to 250 kcal/d
Energy restriction, walking, protein and WB-EMS
Energy restriction of 250 kcal/d, increased energy consumption by walking (250 kcal/d), total protein uptake (including supplementation) of 1.5 g/kg body mass/d and WB-EMS application 1,5x 20 min/week
Protein
Protein supplementation 1.2 or 1.5 g/kg body mass/d
Walking
Walking with a volume corresponding to 250 kcal/d
WB-EMS application
WB-EMS application 1.5x 20 min/week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Protein
Protein supplementation 1.2 or 1.5 g/kg body mass/d
Walking
Walking with a volume corresponding to 250 kcal/d
WB-EMS application
WB-EMS application 1.5x 20 min/week
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* overweight/obesity (body fat rate equal or higher 30%)
Exclusion Criteria
* pregnant or parturition \< 6 months
* any condition or medication that prevent proper physical activity or WB-EMS application
* holidays equal or more than 1 week during the intervention period
* other interventions with impact on the primary and core secondary outcome (i.e. body fat parameters) started during the last year.
25 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Erlangen-Nürnberg Medical School
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wolfgang Kemmler
Professor Dr. Wolfgang Kemmler, Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simon von Stengel, PhD
Role: STUDY_CHAIR
Institute of Medical Physics, FAU Erlangen-Nürnberg, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Medical Physics University of Erlangen-Nurnberg
Erlangen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WREPP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.